Xaira Therapeutics
Founded Year
2023Stage
Series A | AliveTotal Raised
$1BLast Raised
$500M | 1 yr agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+14 points in the past 30 days
About Xaira Therapeutics
Xaira Therapeutics operates as a biotechnology company focused on drug discovery and development through the application of artificial intelligence. The company specializes in creating computational methods, models, and data sets to enhance the process of discovering and developing new therapeutics. Xaira Therapeutics primarily serves the biotechnology and pharmaceutical sectors. It was founded in 2023 and is based in South San Francisco, California.
Loading...
Loading...
Research containing Xaira Therapeutics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Xaira Therapeutics in 4 CB Insights research briefs, most recently on May 23, 2025.
May 23, 2025
The AI in drug R&D market map
Jan 16, 2025 report
State of Digital Health 2024 Report
Expert Collections containing Xaira Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Xaira Therapeutics is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,276 items
Generative AI
2,314 items
Companies working on generative AI applications and infrastructure.
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Artificial Intelligence
10,047 items
AI in drug discovery
521 items
Companies using AI to advance therapeutic discovery, categorized into: platforms (primary product is software) and discovery engines (primary product is therapeutics). Additional funnel descriptions reflect how companies are applying AI.
Latest Xaira Therapeutics News
Jun 26, 2025
Traditional drug discovery is something of a blend of artisanal craft and engineering. To help push the field towards industrialization, Xaira Therapeutics, the $1 billion AI drug discovery unicorn co-founded by Nobel laureate David Baker, has released X-Atlas/Orion, an 8-million-cell open-source dataset detailing not just if a genetic change affects a cell, but by how… The post How Xaira aims to fuel biology’s ‘ImageNet moment’ with a 521-GB open-source dataset for training biological foundation models appeared first on Research & Development World.
Xaira Therapeutics Frequently Asked Questions (FAQ)
When was Xaira Therapeutics founded?
Xaira Therapeutics was founded in 2023.
Where is Xaira Therapeutics's headquarters?
Xaira Therapeutics's headquarters is located at 700 Gateway Boulevard, South San Francisco.
What is Xaira Therapeutics's latest funding round?
Xaira Therapeutics's latest funding round is Series A.
How much did Xaira Therapeutics raise?
Xaira Therapeutics raised a total of $1B.
Who are the investors of Xaira Therapeutics?
Investors of Xaira Therapeutics include Foresite Capital, ARCH Venture Partners, RSquared, F-Prime Capital, Menlo Ventures and 11 more.
Loading...
Loading...